Phosphoinositide 3-kinase δ inhibitor suppresses IL-17 expression in a murine model of asthma

J. P. Seoung, H. Moon, S. R. Kim, K. S. Lee, H. J. Han, M. H. Lee, Y. C. Lee (Jeonju, Republic Of Korea)

Source: Annual Congress 2009 - Animal models of airways inflammation
Session: Animal models of airways inflammation
Session type: E-Communication Session
Number: 4738
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. P. Seoung, H. Moon, S. R. Kim, K. S. Lee, H. J. Han, M. H. Lee, Y. C. Lee (Jeonju, Republic Of Korea). Phosphoinositide 3-kinase δ inhibitor suppresses IL-17 expression in a murine model of asthma. Eur Respir J 2009; 34: Suppl. 53, 4738

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Phosphoinositide 3-kinase ? inhibitor suppresses interleukin-17 expression in a murine asthma model
Source: Eur Respir J 2010; 36: 1448-1459
Year: 2010



The pan janus kinase (JAK) inhibitor KN-002 suppresses inflammatory mediator release from severe asthma bronchial epithelial cells.
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021


The effect of smoking on phosphoinositide 3-kinase (PI3K) and phosphatase and tensin homolog deleted from chromosome 10 (PTEN) mRNA expression in human airway epithelial cells
Source: International Congress 2014 – Mechanistic studies of the airway epithelium
Year: 2014


Activation of second messenger pathways in alveolar macrophages by endotoxin
Source: Eur Respir J 2002; 20: 210-222
Year: 2002



Inhibition of P38 kinase does not reduce production of TNF-alpha from airway cells in COPD
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007


Gene transfer of a β-adrenergic receptor kinase inhibitor up-regulated levels of β-adrenergic receptor and cAMP in asthmatic murine lung
Source: Eur Respir J 2005; 26: Suppl. 49, 580s
Year: 2005

A phosphatidylinositol 3-kinase Inhibitor strongly suppressed pulmonary vascular remodeling in a murine model of allergic vasculitis
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015

Phosphatidylinositol 3-kinase signaling is required for the differentiation of naive cells to CD103(αEβ7)+/CD4+-T-lymphocytes
Source: Eur Respir J 2004; 24: Suppl. 48, 38s
Year: 2004

RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-a and -? selectivity, suppresses COPD inflammation
Source: Eur Respir J, 50 (4) 1700188; 10.1183/13993003.00188-2017
Year: 2017



Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-alpha and Haemophilus influenzae in human bronchial epithelial cells
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

Differential actions of phosphatidyinositol 3-kinase inhibitors on respiratory burst and leukotriene C4 generation in PAF-stimulated human eosinophils
Source: Eur Respir J 2003; 22: Suppl. 45, 547s
Year: 2003

Inhibition of the glycogen synthase kinase 3β reduces steroid function in human monocytes
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010

Regulation of cytokine- and phorbol ester-mediated interleukin (IL)-8 expression in the absence or presence of pyocyanin in human bronchial epithelial cell line: roles of protein kinase C and mitogen-activated protein kinases
Source: Eur Respir J 2005; 26: Suppl. 49, 99s
Year: 2005

Inhibition of VEGF blocks the activation of TGF-β1 through a PI3K/Akt signaling pathway in allergic airway disease of mice
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007


Regulation and overexpression of 85-kDa cytosolic phospholipase A2 in asthma
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010


LATE-BREAKING ABSTRACT: Evaluation of an oral p38 mitogen activated protein kinase (MAPK inhibitor) SB-681323 in COPD
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009


Group V phospholipase A2 (gVPLA2) -induced eosinophil synthesis of LTC4 is independent of mitogen-activated protein kinases (MAPK) activation
Source: Eur Respir J 2001; 18: Suppl. 33, 408s
Year: 2001

C/EBP-β expression in mesothelioma cells is regulated by mitogen activated protein kinase p38-β and –gamma
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009


Endothelin-1 activates pro-inflammatory signalling pathway via destinct p38MAPK isoforms resulting in downregulation of nuclear p27kip1
Source: Annual Congress 2009 - Airway cell biology
Year: 2009


Inhibition of glycogen synthase kinase 3beta reduces GC function in human monocytes via modulation of HDAC2 activity
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011